Cencora Inc. (COR)
Official siteHEALTHCARE • MEDICAL DISTRIBUTION • NYSE
Market Cap: $68.51B
Last updated: Nov 17, 2026 at 11:05 AM ET
Cencora Inc. (COR) Stock Forecast
Analysts expect Cencora (COR) to earn $19.62 per share in the fiscal year ending Sep 30, 2027, on revenue of $352.19B. Of 14 analysts, 10 rate the stock Buy or Strong Buy, 4 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 2 estimates for the fiscal year ending Sep 30, 2027 were revised up and 2 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 14 ratings average 2.07, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 71% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 3 | 21.4% |
| Buy | 7 | 50.0% |
| Hold | 4 | 28.6% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 14
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 10.6% and revenue estimates rise 4.9%.
- Fiscal year ending Sep 30, 2027
- $19.62
- EPS consensus, revenue $352.19B
- Fiscal year ending Sep 30, 2028
- $21.70
- EPS consensus, revenue $369.40B
- Next report
- Feb 2, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Sep 30, 2027 | $19.62 | $19.40 to $19.77 | 7 | $352.19B | $349.85B to $354.92B | 8 |
| Sep 30, 2028 | $21.70 | $21.19 to $22.32 | 8 | $369.40B | $364.85B to $372.76B | 7 |
Quarterly Estimates
The EPS consensus rises from $4.62 for the quarter ending Dec 31, 2026 to $5.17 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $4.62 | $4.53 to $4.94 | 6 | $90.31B | $89.53B to $91.08B | 6 |
| Mar 31, 2027 | $5.17 | $4.57 to $5.45 | 6 | $82.22B | $81.65B to $82.72B | 6 |
Estimate Revisions
Across the 4 periods below, the last 30 days brought 4 upward and 7 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Sep 30, 2027 | 2 | 2 |
| Fiscal year ending Sep 30, 2028 | 0 | 4 |
| Quarter ending Dec 31, 2026 | 1 | 0 |
| Quarter ending Mar 31, 2027 | 1 | 1 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Sep 30, 2027 has fallen 1.0% from $19.81.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Sep 30, 2027 | $19.62 | $19.76 | $19.80 | $19.81 | $19.81 | -0.9% |
| Fiscal year ending Sep 30, 2028 | $21.70 | $21.93 | $22.04 | $22.06 | $22.06 | -1.6% |
| Quarter ending Dec 31, 2026 | $4.62 | $4.58 | $4.60 | $4.60 | $4.56 | +1.5% |
| Quarter ending Mar 31, 2027 | $5.17 | $5.18 | $5.19 | $5.18 | $5.18 | -0.3% |
Frequently Asked Questions About COR
What is the COR stock forecast?
Consensus analyst estimates put Cencora's EPS at $19.62 for the fiscal year ending Sep 30, 2027, on revenue of $352.19B. The consensus rating from 14 analysts is Buy.
How do analysts rate COR stock?
Of 14 analysts covering Cencora, 3 rate it Strong Buy, 7 Buy, 4 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from COR next year?
For the fiscal year ending Sep 30, 2027, the consensus EPS estimate is $19.62, with estimates from $19.40 to $19.77 from 7 analysts. For the fiscal year ending Sep 30, 2028, the consensus EPS estimate is $21.70, with estimates from $21.19 to $22.32 from 8 analysts.
What revenue do analysts expect from Cencora next year?
For the fiscal year ending Sep 30, 2027, the consensus revenue estimate is $352.19B, with estimates from $349.85B to $354.92B. For the fiscal year ending Sep 30, 2028, the consensus revenue estimate is $369.40B, with estimates from $364.85B to $372.76B.
How many analysts cover COR?
14 analysts rate Cencora stock, and 7 analysts estimate its EPS for the fiscal year ending Sep 30, 2027.
COR pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts